News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients

News

January 31, 2024
PRESS RELEASE: On January 24, 2024, a new research paper was published in Oncotarget, entitled, “BCAS1 defines a heterogeneous cell population in diffuse gliomas.” continue reading »

XRCC1: A Potential Prognostic and Immunological Biomarker in Low-Grade Gliomas

Aging

January 30, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis.” continue reading »

Genetic Alterations in Thyroid Cancer Mediate Resistance to BRAF Inhibition and Anaplastic Transformation

News

January 29, 2024
PRESS RELEASE: On January 24, 2024, a new research perspective was published in Oncotarget, entitled, “Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.” continue reading »

Targeting FSP1 Regulates Iron Homeostasis in Drug-tolerant Persister Head and Neck Cancer Cells

Aging

January 24, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.” continue reading »

Case Report: Lazarus Effect in a Patient Treated With Osimertinib for NSCLC With Leptomeningeal Disease

News

January 24, 2024
PRESS RELEASE: On January 16, 2024, a new case report was published in Oncotarget, entitled, “Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report.” continue reading »